vs
Orthofix Medical Inc.（OFIX）与狮门娱乐（STRZ）财务数据对比。点击上方公司名可切换其他公司
狮门娱乐的季度营收约是Orthofix Medical Inc.的1.5倍（$320.9M vs $219.9M），Orthofix Medical Inc.净利率更高（-1.0% vs -16.4%，领先15.4%），Orthofix Medical Inc.同比增速更快（2.0% vs -7.5%），Orthofix Medical Inc.自由现金流更多（$16.8M vs $-31.3M），过去两年Orthofix Medical Inc.的营收复合增速更高（8.0% vs -40.6%）
Orthofix医疗是全球知名骨科医疗器械企业，专注于研发、生产及销售脊柱植入物、骨科创伤产品、骨生长刺激治疗设备及再生医疗产品，服务全球多地的骨科医师与医疗机构，致力于提升肌肉骨骼疾病患者的诊疗效果。
Starz娱乐集团（原狮门娱乐）是一家加拿大裔美国合资娱乐企业，1997年由弗兰克·朱斯特拉创立，目前总部坐落于加利福尼亚州圣莫尼卡，注册经营原籍为不列颠哥伦比亚省温哥华，在影视内容制作发行领域拥有深厚行业积淀。
OFIX vs STRZ — 直观对比
营收规模更大
STRZ
是对方的1.5倍
$219.9M
营收增速更快
OFIX
高出9.5%
-7.5%
净利率更高
OFIX
高出15.4%
-16.4%
自由现金流更多
OFIX
多$48.1M
$-31.3M
两年增速更快
OFIX
近两年复合增速
-40.6%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $219.9M | $320.9M |
| 净利润 | $-2.2M | $-52.6M |
| 毛利率 | 71.1% | — |
| 营业利润率 | 0.2% | -10.8% |
| 净利率 | -1.0% | -16.4% |
| 营收同比 | 2.0% | -7.5% |
| 净利润同比 | 92.4% | -71.9% |
| 每股收益（稀释后） | $-0.05 | $-3.15 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收OFIXSTRZ
| Q4 25 | $219.9M | — | ||
| Q3 25 | $205.6M | $320.9M | ||
| Q2 25 | $203.1M | $319.7M | ||
| Q1 25 | $193.6M | — | ||
| Q4 24 | $215.7M | $970.5M | ||
| Q3 24 | $196.6M | $346.9M | ||
| Q2 24 | $198.6M | $347.6M | ||
| Q1 24 | $188.6M | — |
净利润OFIXSTRZ
| Q4 25 | $-2.2M | — | ||
| Q3 25 | $-22.8M | $-52.6M | ||
| Q2 25 | $-14.1M | $-42.5M | ||
| Q1 25 | $-53.1M | — | ||
| Q4 24 | $-29.1M | $-21.9M | ||
| Q3 24 | $-27.4M | $-30.6M | ||
| Q2 24 | $-33.4M | $4.2M | ||
| Q1 24 | $-36.0M | — |
毛利率OFIXSTRZ
| Q4 25 | 71.1% | — | ||
| Q3 25 | 72.2% | — | ||
| Q2 25 | 68.7% | — | ||
| Q1 25 | 62.8% | — | ||
| Q4 24 | 69.0% | — | ||
| Q3 24 | 68.7% | — | ||
| Q2 24 | 67.8% | — | ||
| Q1 24 | 67.5% | — |
营业利润率OFIXSTRZ
| Q4 25 | 0.2% | — | ||
| Q3 25 | -8.3% | -10.8% | ||
| Q2 25 | -7.9% | -8.4% | ||
| Q1 25 | -25.2% | — | ||
| Q4 24 | -5.3% | 3.7% | ||
| Q3 24 | -9.6% | -4.9% | ||
| Q2 24 | -12.5% | 2.9% | ||
| Q1 24 | -15.6% | — |
净利率OFIXSTRZ
| Q4 25 | -1.0% | — | ||
| Q3 25 | -11.1% | -16.4% | ||
| Q2 25 | -6.9% | -13.3% | ||
| Q1 25 | -27.4% | — | ||
| Q4 24 | -13.5% | -2.3% | ||
| Q3 24 | -13.9% | -8.8% | ||
| Q2 24 | -16.8% | 1.2% | ||
| Q1 24 | -19.1% | — |
每股收益（稀释后）OFIXSTRZ
| Q4 25 | $-0.05 | — | ||
| Q3 25 | $-0.57 | $-3.15 | ||
| Q2 25 | $-0.36 | $-2.54 | ||
| Q1 25 | $-1.35 | — | ||
| Q4 24 | $-0.76 | $-0.09 | ||
| Q3 24 | $-0.71 | $-1.83 | ||
| Q2 24 | $-0.88 | $0.26 | ||
| Q1 24 | $-0.95 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $82.0M | $37.0M |
| 总债务越低越好 | — | $608.7M |
| 股东权益账面价值 | $450.0M | $663.2M |
| 总资产 | $850.6M | $2.0B |
| 负债/权益比越低杠杆越低 | — | 0.92× |
8季度趋势，按日历期对齐
现金及短期投资OFIXSTRZ
| Q4 25 | $82.0M | — | ||
| Q3 25 | $62.9M | $37.0M | ||
| Q2 25 | $65.6M | $51.6M | ||
| Q1 25 | $58.0M | — | ||
| Q4 24 | $83.2M | $200.5M | ||
| Q3 24 | $30.1M | $229.6M | ||
| Q2 24 | $26.4M | $192.5M | ||
| Q1 24 | $27.0M | — |
总债务OFIXSTRZ
| Q4 25 | — | — | ||
| Q3 25 | $157.2M | $608.7M | ||
| Q2 25 | $157.0M | $611.7M | ||
| Q1 25 | $156.9M | — | ||
| Q4 24 | $157.0M | $2.4B | ||
| Q3 24 | $118.5M | $2.1B | ||
| Q2 24 | $118.0M | $1.5B | ||
| Q1 24 | $118.2M | — |
股东权益OFIXSTRZ
| Q4 25 | $450.0M | — | ||
| Q3 25 | $442.5M | $663.2M | ||
| Q2 25 | $458.3M | $712.3M | ||
| Q1 25 | $458.3M | — | ||
| Q4 24 | $503.1M | $-168.3M | ||
| Q3 24 | $525.9M | $935.9M | ||
| Q2 24 | $546.0M | $973.1M | ||
| Q1 24 | $570.3M | — |
总资产OFIXSTRZ
| Q4 25 | $850.6M | — | ||
| Q3 25 | $832.6M | $2.0B | ||
| Q2 25 | $837.2M | $2.1B | ||
| Q1 25 | $823.1M | — | ||
| Q4 24 | $893.3M | $7.2B | ||
| Q3 24 | $867.9M | $7.1B | ||
| Q2 24 | $882.0M | $7.2B | ||
| Q1 24 | $906.0M | — |
负债/权益比OFIXSTRZ
| Q4 25 | — | — | ||
| Q3 25 | 0.36× | 0.92× | ||
| Q2 25 | 0.34× | 0.86× | ||
| Q1 25 | 0.34× | — | ||
| Q4 24 | 0.31× | — | ||
| Q3 24 | 0.23× | 2.24× | ||
| Q2 24 | 0.22× | 1.59× | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $27.7M | $-26.1M |
| 自由现金流经营现金流 - 资本支出 | $16.8M | $-31.3M |
| 自由现金流率自由现金流/营收 | 7.6% | -9.8% |
| 资本支出强度资本支出/营收 | 4.9% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-1.3M | $-317.7M |
8季度趋势，按日历期对齐
经营现金流OFIXSTRZ
| Q4 25 | $27.7M | — | ||
| Q3 25 | $12.4M | $-26.1M | ||
| Q2 25 | $11.6M | $65.4M | ||
| Q1 25 | $-18.4M | — | ||
| Q4 24 | $23.7M | $-335.3M | ||
| Q3 24 | $11.7M | $9.1M | ||
| Q2 24 | $9.0M | $-33.5M | ||
| Q1 24 | $-18.6M | — |
自由现金流OFIXSTRZ
| Q4 25 | $16.8M | — | ||
| Q3 25 | $2.5M | $-31.3M | ||
| Q2 25 | $4.5M | $58.5M | ||
| Q1 25 | $-25.1M | — | ||
| Q4 24 | $15.2M | $-349.3M | ||
| Q3 24 | $6.3M | $4.4M | ||
| Q2 24 | $-360.0K | $-38.4M | ||
| Q1 24 | $-29.1M | — |
自由现金流率OFIXSTRZ
| Q4 25 | 7.6% | — | ||
| Q3 25 | 1.2% | -9.8% | ||
| Q2 25 | 2.2% | 18.3% | ||
| Q1 25 | -13.0% | — | ||
| Q4 24 | 7.0% | -36.0% | ||
| Q3 24 | 3.2% | 1.3% | ||
| Q2 24 | -0.2% | -11.0% | ||
| Q1 24 | -15.4% | — |
资本支出强度OFIXSTRZ
| Q4 25 | 4.9% | — | ||
| Q3 25 | 4.8% | 1.6% | ||
| Q2 25 | 3.5% | 2.2% | ||
| Q1 25 | 3.5% | — | ||
| Q4 24 | 4.0% | 1.4% | ||
| Q3 24 | 2.7% | 1.4% | ||
| Q2 24 | 4.7% | 1.4% | ||
| Q1 24 | 5.6% | — |
现金转化率OFIXSTRZ
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | -7.98× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
OFIX
| Spinal Implants Biologics And Enabling Technologies | $113.6M | 52% |
| Bone Growth Therapies | $68.3M | 31% |
| Other | $22.7M | 10% |
| IT | $5.9M | 3% |
| GB | $3.5M | 2% |
| FR | $3.5M | 2% |
| DE | $2.3M | 1% |
STRZ
| Over The Top Subscription Service OTT | $222.8M | 69% |
| Linear Subscription Service | $98.1M | 31% |
